Pancreas Cancer Symposium: State-of-the-Art 2018 and Beyond
In-Person Event
Nov 30, 2018
New York City, New York, USA
OVERVIEW
Pancreas Cancer Symposium: State-of-the-Art 2018 and Beyond is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held on Nov 30, 2018 at Mortimer B. Zuckerman Research Center, New York City, New York, United States of America.
The target audience for this medical event is medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, nursing, advanced practice practitioners, trainees and other disciplines. This CME Conference has been approved for a maximum of 6.75 AMA PRA Category 1 Credits.
Course Description:
Pancreas cancer incidence is on the rise. Treatment paradigms are changing and many novel approaches are under development in this disease. This one day course in conjunction with the Center for Pancreas Cancer Research at Memorial Sloan Kettering is very timely and will review the epidemiology, genomic, molecular and pathologic underpinnings of this disease along with discussing diagnostic and therapeutic approaches for localized, locally advanced and metastatic pancreas adenocarcinoma. An emphasis will be on multidisciplinary decision making and will include a case-based focus. The course will also discuss novel treatments under development and where the field is heading.
In partnership with the David M. Rubenstein Center for Pancreatic Cancer Research
Multidisciplinary Breakout Session | 10:50 am-12:30 pm
This session targets the following providers: Nurses, NP’s, PA’s, Clinical Trial Nurses, Social Workers and Nutritionists. Providers who practice in the Inpatient, Ambulatory Care setting and clinical trials will benefit. Pancreas cancer presents with many challenges. Patients with pancreas cancer have a unique spectrum of disease and treatment-related adverse events which often overlap making care of these patients challenging. Emerging clinical trials with new agents broaden the potential spectrum of toxicities. In this session, a multidisciplinary team will address the complex care needs of these patients.
Course Objectives are:
• Understand the pathologic, genetic and molecular hallmarks of pancreas cancer
• Understand the importance of and where to optimally utilize multidisciplinary care for the management of pancreas cancer
• Outline current diagnostic and surgical strategies for pancreas cancer
• Review the indications and implications of germline and somatic testing in pancreas cancer
• Define the key novel therapeutic approaches for management of pancreas cancer
The target audience for this medical event is medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, nursing, advanced practice practitioners, trainees and other disciplines. This CME Conference has been approved for a maximum of 6.75 AMA PRA Category 1 Credits.
Course Description:
Pancreas cancer incidence is on the rise. Treatment paradigms are changing and many novel approaches are under development in this disease. This one day course in conjunction with the Center for Pancreas Cancer Research at Memorial Sloan Kettering is very timely and will review the epidemiology, genomic, molecular and pathologic underpinnings of this disease along with discussing diagnostic and therapeutic approaches for localized, locally advanced and metastatic pancreas adenocarcinoma. An emphasis will be on multidisciplinary decision making and will include a case-based focus. The course will also discuss novel treatments under development and where the field is heading.
In partnership with the David M. Rubenstein Center for Pancreatic Cancer Research
Multidisciplinary Breakout Session | 10:50 am-12:30 pm
This session targets the following providers: Nurses, NP’s, PA’s, Clinical Trial Nurses, Social Workers and Nutritionists. Providers who practice in the Inpatient, Ambulatory Care setting and clinical trials will benefit. Pancreas cancer presents with many challenges. Patients with pancreas cancer have a unique spectrum of disease and treatment-related adverse events which often overlap making care of these patients challenging. Emerging clinical trials with new agents broaden the potential spectrum of toxicities. In this session, a multidisciplinary team will address the complex care needs of these patients.
Course Objectives are:
• Understand the pathologic, genetic and molecular hallmarks of pancreas cancer
• Understand the importance of and where to optimally utilize multidisciplinary care for the management of pancreas cancer
• Outline current diagnostic and surgical strategies for pancreas cancer
• Review the indications and implications of germline and somatic testing in pancreas cancer
• Define the key novel therapeutic approaches for management of pancreas cancer
KEY DATES
30 Nov, 2018
Event Start Date
30 Nov, 2018
Event End Date
SPECIALITIES
OncologySUGGESTED HOTELS
CONFERENCE VENUE
Mortimer B. Zuckerman Research CenterRELATED CONFERENCES & LIVE WEBINARS
Quick Links